In 2025, the pharmaceutical industry has become a prime focus of the Trump administration’s healthcare reform agenda. We break down the major threats—where they stand today, and what we’re watching next. | Read more >
Despite the daily barrage of negative headlines, we still believe that we are months, rather than years, away from the end of the pandemic dominating daily behavior. | Read more >
The news coming out of Pfizer’s vaccine trials on November 9th was truly spectacular and triggered a meaningful shift in the stock market. | Read more >